Search

Your search keyword '"E. Bompas"' showing total 161 results

Search Constraints

Start Over You searched for: Author "E. Bompas" Remove constraint Author: "E. Bompas"
161 results on '"E. Bompas"'

Search Results

1. ETIOSARC study : environmental aetiology of sarcomas from a French prospective multicentric population-based case–control study—study protocol

3. Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohort

4. Association between recent pregnancy or hormonal contraceptive exposure and outcome of desmoid-type fibromatosis

6. 1512P Pain in patients with desmoid fibromatosis (DF)

7. 603P Objective computerized cognitive assessment in men with metastatic castrate-resistant prostate cancer (mCRPC) randomly receiving darolutamide or enzalutamide in the ODENZA trial

8. Comment je raisonne devant une masse rétropéritonéale

9. Patient preference between Cabazitaxel and Docetaxel for first-line chemotherapy in metastatic castrate-resistant prostate cancer (mCRPC): Results from the CABADOC randomized trial

10. Transcription Factor E3 and Transcription Factor EB Renal Cell Carcinomas: Clinical Features, Biological Behavior and Prognostic Factors

11. Hypoglycémies organiques dues à une sécrétion paranéoplasique de pro-IGF2 par une tumeur fibreuse solitaire maligne méningée multimétastatique

12. La TEP/TDM au FDG lors du bilan initial prédit la survie chez les adultes atteints de sarcomes d’Ewing

13. Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group

14. Mandibular Osteosarcomas

15. Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network

16. Phase-I study of Innacell gammadelta, an autologous cell-therapy product highly enriched in gamma9delta2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma

17. Management of post-chemotherapy residual masses in advanced seminoma

18. Results from the TARC experiment: Spallation neutron phenomenology in lead and neutron-driven nuclear transmutation by adiabatic resonance crossing

19. Experimental verification of neutron phenomenology in lead and of transmutation by adiabatic resonance crossing in accelerator driven systems: A summary of the TARC Project at CERN

21. [Granulosa cell tumour: review of the literature]

25. 7104 Targeted agents in metastatic Xp11 Translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network

26. Effect of metastasectomy and doxorubicin dose on the outcome of patients with metastastic leiomyosarcoma: A multicenter study

27. Vγ9Vδ2 T (γδ) lymphocytes: a promising approach for immunotherapy of solid tumors

28. An autologous Vγ9Vδ2 T lymphocytes cell therapy product generated by BrHPP (INNACELL Gamma Delta [IGD]) in metastatic renal cell carcinoma patients: Phase I clinical trial results

29. Phase I trial of oral etoposide in combination with radiotherapy in head and neck squamous cell carcinoma - GORTEC 2004–02

30. Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility

31. Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group.

32. A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse.

33. Doxorubicin-Trabectedin with Trabectedin Maintenance in Leiomyosarcoma.

34. Alveolar soft part sarcomas in young patients: The French national NETSARC+ network experience.

35. Long term survival in adult osteosarcoma patients treated with a two-drug regimen: Final results of the OSAD93 phase II study of the FSG-GETO.

36. Discontinuation versus continuation of imatinib in patients with advanced gastrointestinal stromal tumours (BFR14): exploratory long-term follow-up of an open-label, multicentre, randomised, phase 3 trial.

37. Investigating the prognostic impact of NY-ESO-1 expression and HLA subtypes in metastatic synovial sarcoma.

38. PEC-PRO: A new prognostic score from a series of 87 patients with localized perivascular epithelioid cell neoplasms (PEComas) treated with curative intent.

39. Improved nationwide survival of sarcoma patients with a network of reference centers.

40. A Randomized, Open-label, Cross-over Phase 2 Trial of Darolutamide and Enzalutamide in Men with Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer: Patient Preference and Cognitive Function in ODENZA.

41. Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years.

42. Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study.

43. Pembrolizumab monotherapy for advanced chordoma - Authors' reply.

44. Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nationwide series of 267 patients over 12 years.

45. Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial.

46. [Endometrial stromal sarcoma: French Guidelines from the French Sarcoma Group and the Rare Malignant Gynecologic Tumors Group].

47. Late toxicity comparison of alkylating-based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro-EWING99-R1 in France.

48. Patterns of care and outcome of CIC-rearranged sarcoma patients: A nationwide study of the French sarcoma group.

49. Management and outcomes of adolescent and young adult sarcoma patients: results from the French nationwide database NETSARC.

50. Shortening the Time Interval for the Referral of Patients With Soft Tissue Sarcoma to Expert Centers Using Mobile Health: Retrospective Study.

Catalog

Books, media, physical & digital resources